These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8587630)

  • 1. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.
    Paydas S; Gonlusen G; Sagliker Y
    Nephron; 1995; 71(4):463-4. PubMed ID: 8587630
    [No Abstract]   [Full Text] [Related]  

  • 2. Castleman's disease with renal amyloidosis and nephrotic syndrome.
    Arinsoy T; Yilmaz M; Ataoğlu O; Bali M; Sindel S
    Nephrol Dial Transplant; 1997 Dec; 12(12):2713-6. PubMed ID: 9430878
    [No Abstract]   [Full Text] [Related]  

  • 3. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations.
    Curioni S; D'Amico M; Quartagno R; Martino S; Dell'Antonio G; Cusi D
    Nephrol Dial Transplant; 2001 Jul; 16(7):1475-8. PubMed ID: 11427644
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia, and subsequent amyloidosis.
    Chan KW; Lo WK; Cheng IK
    Pathology; 1992 Jul; 24(3):229-30. PubMed ID: 1437301
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal diarrhea in a patient with Castleman's disease associated with intestinal amyloidosis.
    Miura A; Sato I; Suzuki C
    Intern Med; 1995 Nov; 34(11):1106-9. PubMed ID: 8774974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on long-term colchicine treatment. Case report and review of the literature.
    Kagan A; Husza'r M; Frumkin A; Rapoport J
    Nephron; 1999; 82(4):348-53. PubMed ID: 10450037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy.
    Derici U; Arinsoy T; Ataoglu O; Bali M; Eroglu A; Goker B; Sindel S
    Ann Hematol; 2002 Jul; 81(7):399-401. PubMed ID: 12185513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrotic Syndrome Caused by AA Amyloidosis Secondary to Unicentric Castleman's Disease:Report of One Case].
    You RL; Wen YB; Wang J; Ma J; Chen LM; Li XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):540-544. PubMed ID: 35791957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease.
    Menegato MA; Canelles MF; Tonutti E; Pizzolitto S
    Clin Nephrol; 2004 May; 61(5):352-6. PubMed ID: 15182131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine therapy for nephrotic syndrome due to familial Mediterranean fever.
    Skrinskas G; Bear RA; Magil A; Lee KY
    Can Med Assoc J; 1977 Dec; 117(12):1416-7. PubMed ID: 589544
    [No Abstract]   [Full Text] [Related]  

  • 11. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
    Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
    Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary amyloidosis associated with Castleman's disease.
    Tanaka K; Horita M; Shibayama H; Seike M; Itoh Y; Hamaguchi K; Sato Y; Sakata T; Ishida T
    Intern Med; 1995 Feb; 34(2):122-6. PubMed ID: 7727877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of nephrotic syndrome after removal of localized Castleman's disease.
    Keven K; Nergizoğlu G; Ateş K; Erekul S; Orhan D; Ertürk S; Tulunay O; Karatan O; Ertuğ AE
    Am J Kidney Dis; 2000 Jun; 35(6):1207-11. PubMed ID: 10845836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine-sensitive nephrotic syndrome due to AA amyloidosis.
    Hausmann MJ; Maor E; Kachko L
    Amyloid; 2011 Sep; 18(3):169-71. PubMed ID: 21770831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.
    Ordi J; Grau JM; Junqué A; Nomdedeu B; Palacin A; Cardesa A
    Am J Clin Pathol; 1993 Oct; 100(4):394-7. PubMed ID: 8213634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis.
    Sahin G; Korkmaz C; Yalcin AU
    Rheumatol Int; 2008 Jan; 28(3):289-91. PubMed ID: 17703308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.
    Morita-Hoshi Y; Tohda S; Miura O; Nara N
    Int J Hematol; 2008 Jan; 87(1):69-74. PubMed ID: 18224416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation.
    Ogita M; Hoshino J; Sogawa Y; Sawa N; Katori H; Takemoto F; Ubara Y; Hara S; Miyakoshi S; Takaichi K
    Clin Nephrol; 2007 Sep; 68(3):171-6. PubMed ID: 17915620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is colchicine therapy effective in all patients with secondary amyloidosis?
    Unverdi S; Inal S; Ceri M; Unverdi H; Batgi H; Tuna R; Ozturk MA; Guz G; Duranay M
    Ren Fail; 2013 Sep; 35(8):1071-4. PubMed ID: 23841746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine therapy in amyloidosis related with plasmacytic Castleman disease presenting with nephrotic syndrome.
    Paydas S; Paydas S; Ergin M
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):992-5. PubMed ID: 26354576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.